Figure 6.
Figure 6. Different TCR usage between HLA-E tetramer–positive T cells and immunodominant Tax11-19–specific CD8+ T cells from HTLV-1–infected individuals. (A) CDR3 length profiles for TCR transcripts in CD8+ HLA-E tetramer–positive (top row) and HLA-A*02/Tax11-19 tetramer–positive (bottom row) T cells were examined for 4 HLA-A*02+ HAM/TSP patients. A representative result from one HLA-A*02+ HAM/TSP patient is shown. (B) Two-color flow cytometric analysis using HLA-A*02/Tax11-19 tetramer and anti-NKG2A mAb from HLA-A*02+ HAM/TSP patients. Four HLA-A*02+ HAM/TSP patients were examined. A representative result from one HLA-A*02+ HAM/TSP patient is shown.

Different TCR usage between HLA-E tetramer–positive T cells and immunodominant Tax11-19–specific CD8+ T cells from HTLV-1–infected individuals. (A) CDR3 length profiles for TCR transcripts in CD8+ HLA-E tetramer–positive (top row) and HLA-A*02/Tax11-19 tetramer–positive (bottom row) T cells were examined for 4 HLA-A*02+ HAM/TSP patients. A representative result from one HLA-A*02+ HAM/TSP patient is shown. (B) Two-color flow cytometric analysis using HLA-A*02/Tax11-19 tetramer and anti-NKG2A mAb from HLA-A*02+ HAM/TSP patients. Four HLA-A*02+ HAM/TSP patients were examined. A representative result from one HLA-A*02+ HAM/TSP patient is shown.

Close Modal

or Create an Account

Close Modal
Close Modal